About
AboutNovo GroupLeadershipResponsibilityNovo Nordisk Foundation
Investments
InvestmentsAreas
Life Science
Seed InvestmentsVenture InvestmentsGrowth InvestmentsPrincipal InvestmentsBioindustrial Investments
Capital Investments
StrategyRegions
North AmericaEuropeAsia
Portfolio
People & Careers
PeopleCareers
Open positions
News & Reports
News & ReportsFacts & figuresPress FAQMedia library
Nafise Masoumi

Department

Venture Investments

Position

Senior Associate

Nafise joined Venture Investments (US) Inc. in 2020 as an associate.

Prior to joining Venture Investments (US) Inc., Nafise worked at Takeda (Portfolio Strategy Group) & Boston Consulting Group, where she worked with healthcare and Medtech clients on portfolio strategy, R&D optimization, and due diligence projects. Prior to BCG, Nafise was a fellow at Flagship Pioneering and part of the business development team at the Wyss Institute.

She completed her postdoctoral fellow at MIT (Langer lab) and Boston children Hospital (Cardiac Surgery Dept.) working on regenerative medicine and drug delivery platforms. Nafise holds a PhD in Bioengineering from HST and Penn State. She also holds a Msc in Chemical & Biomedical Engineering from Oxford and Sharif University.

Nafise is based in our San Francisco office.

Investing to benefit people and the planet

Novo Holdings A/S

Tuborg Havnevej 19

2900 Hellerup Denmark

+45 3527 6500 CVR# 24257630

Media Relations

Christian Mostrup Scheel

Head of Public Relations

cims@novo.dk +45 3067 4805

Novo Holdings Equity US Inc.*

One Market Plaza, Floor 17 of the Steuart Tower

San Francisco, CA 94105 USA

+1 (415) 363-0858

Novo Holdings Equity Asia Pte. Ltd.*

#40-01, 6 Battery Road

Singapore 049909

Novo Holdings Equity US Inc.*

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

Novo Holdings (UK office)

16 Berkeley Street

London W1J 8DZ

Novo Ventures (US) Inc.*

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

Privacy noticeWhistleblowerArticles of association Policy on data ethicsElectronic invoicingDiversity policy

*Novo Ventures (US) Inc., Novo Holdings Equity US Inc., comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Ltd. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.

Follow us